腹主动脉瘤腔内修复预后预测模型的范围综述
该范围综述基于预设方案检索PubMed、Embase和Cochrane Library(2000–2022年),共筛选8055条文献,纳入52项模型开发研究和48项外部验证研究,识别98个模型。结果显示,新英格兰血管研究组(VSGNE)模型对择期EVAR短期死亡的预测优于Glasgow动脉瘤评分等常用模型,而破裂EVAR、长期死亡与再干预相关模型仍缺乏外部验证,TRIPOD依从性在开发与验证研究中分别平均为63.59%和51.58%。
要点
- 择期EVAR短期死亡预测中,VSGNE模型表现优于Glasgow动脉瘤评分、Giles与Vascular Governance North West等常用模型。
- Vascular Quality Initiative 1年生存模型对长期死亡预测表现更优,但仍需外部验证。
- 破裂EVAR短期死亡以Dutch Aneurysm Score预测最佳,但各研究间表现不一致。
核心结论
- 择期EVAR的短期死亡可用VSGNE模型可靠预测。
- 破裂EVAR、长期死亡与再干预的临床相关模型缺乏外部验证,缺失数据处理不当、收缩方法使用有限和校准报告不佳限制其临床效用。
- 亟需聚焦外部验证现有多中心模型的稳健研究。
研究设计与样本
- 研究为基于PRISMA-ScR框架预设方案的范围综述,检索PubMed、Embase和Cochrane Library 2000–2022年文献。
- 共筛选8055条引文,纳入52项开发研究和48项外部验证研究,识别98个模型。
- 数据提取采用CHARMS、PROBAST与TRIPOD工具改编。
主要发现
- VSGNE模型在短期死亡预测上优于Glasgow Aneurysm Score、Giles和Vascular Governance North West等常用模型。
- VQI 1年生存模型在长期死亡预测上表现更优但需外部验证。
- Müller-Wille等、Kaladji等与Mid-Essex人工神经网络模型对其它并发症判别力强但需进一步验证。
- rEVAR亚组中Dutch Aneurysm Score对短期死亡预测最佳,但研究间表现不一。
- TRIPOD依从性在开发与验证研究中平均分别为63.59%和51.58%,偏倚风险以分析域最高。
关键数值与推荐
- 纳入98个预测模型,来自52项开发研究与48项外部验证研究(2000–2022年检索)。
- TRIPOD依从性:开发研究平均63.59%,验证研究平均51.58%。
临床怎么用
- 择期EVAR术前风险分层可优先参考VSGNE模型预测短期死亡。
- 长期死亡可参考VQI 1年生存模型,但应认识到其尚待外部验证。
- 使用现有模型时需警惕缺失数据处理、收缩方法不足与校准报告不佳带来的临床效用限制。
局限性
- 多数临床相关模型(rEVAR、长期死亡、再干预)缺乏外部验证。
- 缺失数据处理不当、收缩方法使用有限、校准报告不佳影响模型临床效用。
- 偏倚风险在分析域最高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Numerous prediction models have been developed to support the challenge of preoperative risk stratification and postoperative follow-up for endovascular repair (EVAR) of infrarenal abdominal aortic aneurysms. This scoping review aims to determine which models have clinical utility based on predictive performance. METHODS: An a-priori protocol based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews framework was developed. PubMed, Embase, and Cochrane Library were searched for studies published between 2000 and 2022. Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modeling Studies guidelines, Prediction model Risk of Bias Assessment Tool and Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) tools were adapted for data extraction. RESULTS: Among 8,055 screened citations, 52 development and 48 external validation studies met the eligibility criteria, identifying 98 models. The Vascular Study Group of New England (VSGNE) model outperformed popular models such as Glasgow Aneurysm Score, Giles, and Vascular Governance North West for predicting short-term mortality. The Vascular Quality Initiative 1-year survival model model showed superior performance for long-term mortality but requires external validation. Several models predicting other complications (Müller-Wille et al., Kaladji et al., Mid-Essex Artificial Neural Network) showed strong discrimination but require further validation. In the ruptured endovascular aneurysm repair (rEVAR) subgroup, the Dutch Aneurysm Score model best predicted short-term mortality but performance was variable between studies. TRIPOD adherence averaged 63.59% and 51.58% for development and validation studies respectively. Risk of bias was highest in analysis domains. CONCLUSION: Short-term mortality in elective EVAR could be reliably predicted using the VSGNE model. However, clinically relevant models for rEVAR, long-term mortality and reintervention lack external validation, and issues such as inadequate handling of missing data, limited use of shrinkage methods, and poor calibration reporting hinder their clinical utility. Robust multicenter studies focused on externally validating existing models are essential to address these limitations.
引用
- Ul-Mulk Z, Tobias S, Khan UF, et al. Scoping Review of Prognostic Prediction Models for Endovascular Abdominal Aortic Aneurysm Repair. Ann Vasc Surg. 2025. PMID: 40706842. doi:10.1016/j.avsg.2025.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。